Drug companies lobby against generic versions of biologics
Year: 2013
Type: other
Source: BMJ
DOI: 10.1136/bmj.f740
Author: M. E. Tucker
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W2013243363
